The landscape of blood sugar treatment is advancing with the emergence of skin-applied GLP-1 therapy. These innovative devices offer a likely simpler alternative to needle administrations for individuals living with type 2 diabetes . Such a system deliver a GLP-1 agonist directly through the epidermis, circumventing the necessity for frequent injec